Newsroom | 10327 results

Sorted by: Latest

Mental Health
-

Aegis Sciences Names Joel Galanter Interim CEO

NASHVILLE, Tenn.--(BUSINESS WIRE)--Aegis Sciences Corporation (“Aegis” or the “Company”) today announced it has named Joel Galanter Interim CEO, replacing Frank Basile who served as the company’s CEO since 2017. With more than a decade in senior executive leadership at Aegis, Galanter brings deep institutional knowledge and broad experience across the Company's operations, regulatory environment, and strategic priorities. Galanter has directly overseen the Company's legal, regulatory, governmen...
-

Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

DUBLIN--(BUSINESS WIRE)--Prothena reported financial results for the second quarter and first six months of 2026 and provided business highlights....
-

Cerepeut's Lead Compound Shows How a Little-Known Mitochondrial Mechanism Fuels Neurodegeneration, and How to Stop It

SAN CARLOS, Calif.--(BUSINESS WIRE)--Cerepeut, Inc., a biotechnology company developing mitochondrial therapeutics for neurodegenerative disease, today announced publication of a landmark study in Neuron revealing why the brain turns on itself in Alzheimer's disease and related disorders, and unveiling a drug candidate designed to stop it. Tau is a well-known driver of Alzheimer's, notorious for clumping into toxic tangles inside dying neurons. What scientists didn't know was that tau also moon...
-

New Reframe Data: July 4th Was America's Biggest Drinking Day of 2026 — Bigger Than Christmas

ATLANTA--(BUSINESS WIRE)--Fireworks weren't the only thing peaking on the Fourth of July. According to new data from Reframe, the leading alcohol-reduction app in the U.S. with the largest user base, July 4th was the single biggest drinking day of 2026 so far. Among users who drank that day, consumption averaged nearly five drinks per person, more than Christmas Day, and second only to New Year's Eve over the past twelve months. In years when the holiday falls midweek, drinking runs as much as...
-

Millie Expands Access to Coordinated Technology-Enabled Maternity Care in Northern California

SAN FRANCISCO--(BUSINESS WIRE)--Millie, the tech-enabled women’s health clinic, today announced that it will join UCSF Health Medical Foundation’s clinically integrated network, creating seamless care experiences for patients that combine Millie's distinctive midwifery-led, technology-enabled maternity care model with UCSF Health's world-class expertise when more specialized care is needed. The move comes as Millie continues to expand access to high-quality pregnancy, birth and postpartum care...
-

Aramark Student Nutrition Sets a New Standard for Student Wellbeing This Back-to-School Season

PHILADELPHIA--(BUSINESS WIRE)--Aramark Student Nutrition is launching the 2026-2027 school year with a nationwide effort to remove artificial dyes and additives from school menus, as announced in June, becoming the first national K-12 foodservice provider to implement the change across participating school districts. The initiative will impact thousands of students in more than 350 school districts and is part of Aramark's broader strategy to support student health, academic success, mental wel...
-

Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026, and will participate in a fireside chat at 8:00am ET. Management will also participate in the Stifel Biotech Summit in Newport, Rhode Island, on August 10, 2026. A live audio webcast of this event wil...
-

Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.S. Department of Verterans Affairs (VA) on a multi-site randomized controlled clinical trial. The study will evaluate the safety and efficacy of COMP360 psilocybin in the treatment of treatment-resistant depression (TRD) in veterans, including those with concurrent post-trauma...
-

Samenvatting: Clinilabs kondigt benoemingen van medische bestuursleden aan

EATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs (“Clinilabs LLC”), een internationale full-service CRO (contract research organization) gespecialiseerd in de ontwikkeling van CNS-geneesmiddelen (Central Nervous System) en -hulpmiddelen, kondigde vandaag de benoeming aan van Bob Dagher , M.D., tot Chief Medical Officer en van Waqar Ahmed Siddiqui , M.D., tot Principal Investigator van de CRU (Clinical Research Unit) van het bedrijf in Eatontown, New Jersey. Dr. Dagher zal instaan voor strategisch en...
-

Clinilabs annonce des nominations au sein de sa direction médicale

EATONTOWN, New Jersey--(BUSINESS WIRE)--Clinilabs (« Clinilabs LLC »), une organisation de recherche sous contrat (CRO) mondiale offrant une gamme complète de services et spécialisée dans le développement de médicaments et de dispositifs destinés au système nerveux central (SNC), a annoncé aujourd’hui la nomination du Dr Bob Dagher, au poste de CMO et du Dr Waqar Ahmed Siddiqui, au poste de chercheur principal de l'unité de recherche clinique (URC) de la société à Eatontown, dans le New Jersey....